See what questions
a doctor would ask.
The FDA has approved the use of Vioxx for children suffering from common forms of juvenile rheumatoid arthritis (pauciarticular, polyarticular). The children need to be over 2 years old and weigh more than 22 pounds. Vioxx has already been approved for use in treatment of severe migraine in adults. The approval was based on a study involving 310 patients.
Source: summary of medical news story as reported by News Target Network
About: Vioxx approved for treatment of juvenile rheumatoid arthritis
Date: 7 December 2004
Source: News Target Network
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City